Penserra Capital Management LLC Precigen, Inc. Transaction History

Penserra Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$3.53 - $5.5 $16,679 - $25,987	-4,725 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$4.99 - $6.55 $124 - $163	25 Added 0.53%	4,725 $23,000
Q2 2021 Aug 12, 2021	BUY	$6.24 - $8.22 $655 - $863	105 Added 2.29%	4,700 $30,000
Q1 2021 May 13, 2021	BUY	$6.74 - $10.95 $2,291 - $3,722	340 Added 7.99%	4,595 $31,000
Q4 2020 Feb 12, 2021	BUY	$3.75 - $10.56 $10,436 - $29,388	2,783 Added 189.06%	4,255 $43,000
Q3 2020 Nov 13, 2020	BUY	$3.5 - $6.2 $5,152 - $9,126	1,472 New	1,472 $5,000
Q2 2020 Aug 14, 2020	SELL	$2.16 - $5.46 $6,588 - $16,653	-3,050 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$1.46 - $7.19 $4,453 - $21,929	3,050 New	3,050 $9,000

141

159M

232K

69K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $231M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.